{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:52:04Z","timestamp":1764402724582,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jsat.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T14:09:39Z","timestamp":1462716579000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["One-Year Follow-Up of Heroin-Dependent Adolescents Treated with Buprenorfine\/Naloxone for the First Time in a Substance Treatment Unit"],"prefix":"10.1016","volume":"67","author":[{"given":"Caner","family":"Mutlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu Ciftci","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozhan","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Guven","family":"Kilicoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melike","family":"Topal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gul","family":"Karacetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsat.2016.04.002_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0376-8716(89)90062-8","article-title":"The reliability and validity of the WHO student drug-use questionnaire among Nigerian students","volume":"24","author":"Adelekan","year":"1989","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2016.04.002_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: Five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2016.04.002_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"year":"2000","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.jsat.2016.04.002_bb0020"},{"key":"10.1016\/j.jsat.2016.04.002_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7517-7-29","article-title":"Opioid substitution therapy in Manipur and Nagaland, north-east India: Operational research in action","volume":"7","author":"Armstrong","year":"2010","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.jsat.2016.04.002_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2012.11.002","article-title":"Trends of heroin use and heroin injection epidemics in Europe: Findings from the EMCDDA treatment demand indicator (TDI)","volume":"45","author":"Barrio","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.04.002_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09595230500537670","article-title":"Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: A file review","volume":"25","author":"Bell","year":"2006","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2016.04.002_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","article-title":"Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention","volume":"104","author":"Burns","year":"2009","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2016.04.002_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00952990.2014.983272","article-title":"Liver enzyme levels in adolescent patients treated with buprenorphine and additional psychotropic agents","volume":"41","author":"Ciftci Demirci","year":"2015","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2016.04.002_bb0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2012.12.010","article-title":"Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study","volume":"131","author":"Dreifuss","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2016.04.002_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine\u2013naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2016.04.002_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphine\/naloxone in primary care: Results at 2\u20135 years","volume":"17","author":"Fiellin","year":"2008","journal-title":"The American Journal on Addictions"},{"issue":"1","key":"10.1016\/j.jsat.2016.04.002_bb0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.04.002_bb0070","article-title":"Buprenorphine for the management of opioid withdrawal","volume":"3","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.jsat.2016.04.002_bb0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0740-5472(02)00250-7","article-title":"Adolescent heroin use: A review of the descriptive and treatment literature","volume":"23","author":"Hopfer","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2016.04.002_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"year":"2011","series-title":"Monitoring the future: national results on adolescent drug use: Overview of key findings, 2010","author":"Johnston","key":"10.1016\/j.jsat.2016.04.002_bb0085"},{"key":"10.1016\/j.jsat.2016.04.002_bb0090","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-Year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jsat.2016.04.002_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00952990802585380","article-title":"Brief vs. extended buprenorphine detoxification in a community treatment program: Engagement and short-term outcomes","volume":"35","author":"Katz","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2016.04.002_bb0100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: A randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.jsat.2016.04.002_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/ADM.0000000000000035","article-title":"A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine\/naloxone clinic","volume":"8","author":"Matson","year":"2014","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2016.04.002_bb0110","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.04.002_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1370\/afm.665","article-title":"Treating opioid addiction with buprenorphine\u2013naloxone in community-based primary care settings","volume":"5","author":"Mintzer","year":"2007","journal-title":"Annals of Family Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2016.04.002_bb0120","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/00952999609001678","article-title":"A pilot study of primary-care-based buprenorphine maintenance for heroin dependence","volume":"22","author":"O'Connor","year":"1996","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2016.04.002_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(00)80006-X","article-title":"Buprenorphine: A controlled clinical trial in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2016.04.002_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2016.04.002_bb0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsat.2014.04.006","article-title":"Emerging adult age status predicts poor buprenorphine treatment retention","volume":"47","author":"Schuman-Olivier","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2016.04.002_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2011.07.007","article-title":"Outcome of heroin-dependent adolescents presenting for opiate substitution treatment","volume":"42","author":"Smyth","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2016.04.002_bb0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.jsat.2016.04.002_bb0150","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"Journal of General Internal Medicine"},{"issue":"11","key":"10.1016\/j.jsat.2016.04.002_bb0155","first-page":"1120","article-title":"Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine\/naloxone treatment trial in opioid-dependent youth","volume":"50","author":"Subramaniam","year":"2011","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"article-title":"Treatment episode data set (TEDS). 1999\u20132009.","year":"2011","author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.jsat.2016.04.002_bb0160"},{"year":"2012","series-title":"Treatment episode data set (TEDS): 2000\u20132010. National Admissions to Substance Abuse Treatment Services. DASIS series S-61, HHS publication no. (SMA) 12\u20134701","author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.jsat.2016.04.002_bb0165"},{"issue":"1","key":"10.1016\/j.jsat.2016.04.002_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1521-0391.2011.00186.x","article-title":"Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","volume":"21","author":"Tkacz","year":"2012","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2016.04.002_bb0175","series-title":"World drug report","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.18356\/d30739c2-en","author":"United Nations Office of Drugs and Crime (UNODC)","year":"2013"},{"issue":"9","key":"10.1016\/j.jsat.2016.04.002_bb0180","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2016.04.002_bb0185","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs. shortterm buprenorphine\u2013naloxone for treatment of opioid-addicted youth: A randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jsat.2016.04.002_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.addbeh.2006.03.043","article-title":"Is inhalant use a risk factor for heroin and injection drug use among adolescents in the United States?","volume":"32","author":"Wu","year":"2007","journal-title":"Addictive Behaviors"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216300496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216300496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:44:05Z","timestamp":1760039045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216300496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":38,"alternative-id":["S0740547216300496"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2016.04.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-Year Follow-Up of Heroin-Dependent Adolescents Treated with Buprenorfine\/Naloxone for the First Time in a Substance Treatment Unit","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}